RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
8.84
-0.73 (-7.63%)
At close: Jan 9, 2026, 4:00 PM EST
9.14
+0.30 (3.39%)
After-hours: Jan 9, 2026, 7:44 PM EST
RxSight Market Cap
RxSight has a market cap or net worth of $363.47 million as of January 9, 2026. Its market cap has decreased by -73.21% in one year.
Market Cap
363.47M
Enterprise Value
147.52M
1-Year Change
-73.21%
Ranking
Category
Stock Price
$8.84
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $363.47M, a decrease of -14.34%. That is a compound annual growth rate of -3.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 393.49M | -8.16% |
| Dec 31, 2025 | 428.44M | -69.08% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
| Jul 30, 2021 | 424.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 992.16B |
| Johnson & Johnson | 499.90B |
| AbbVie | 412.54B |
| UnitedHealth Group | 309.53B |
| AstraZeneca | 297.23B |
| Novartis AG | 273.49B |
| Merck & Co. | 269.55B |
| Novo Nordisk | 254.60B |